findmyKOL

Rakesh Gopinathannair, MD

Enriched profile

Director of Cardiac Electrophysiology Laboratories, Kansas City Heart Rhythm Institute · Kansas City Heart Rhythm Institute

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Overland Park, KS · Midwest · United StatesSpecialtyClinical Cardiac ElectrophysiologyFocusHeart Failure
Active KOLfindmyKOL type: EliteLatest publication2026Online presenceverified 2026Payments2021–2025NIH fundingNone on fileWhy? →

Rakesh Gopinathannair is Director of Cardiac Electrophysiology Laboratories, Kansas City Heart Rhythm Institute at Kansas City Heart Rhythm Institute. OpenAlex indexes 433 publications with 9,626 citations (h-index 41); ClinicalTrials.gov lists 3 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Clinical Cardiac Electrophysiology profiles in the findmyKOL directory.

Data verified 14 Aug 2026

Overview

Updated 14 Oct 2026

Rakesh Gopinathannair, MD, MA, is Director of Cardiac Electrophysiology Laboratories, Kansas City Heart Rhythm Institute. The public record shows 433 publications with 9,626 citations (h-index 41), centered on Heart Failure. It also documents an investigator role on 3 registered clinical trials, industry payments reported by 27 companies.

  • Most recent indexed publication: 2026 · Journal of cardiovascular electrophysiology
  • Top research focus: Heart Failure
  • 3 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 27 companies

Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Heart Failure2 trialsCoronavirus Infections1 trialVirus Diseases1 trialAtrial Fibrillation1 trialHeart Failure, Diastolic1 trial

Research focus

OpenAlex concept fingerprint
Heart Failure

Drugs & molecules

across trials, industry payments and publications
Multaqgeneric · DronedaroneClinical trials—Industry payments13Publications—Eliquisgeneric · ApixabanClinical trials—Industry payments11Publications—SotalolClinical trials—Industry payments6Publications—Vyndaqelgeneric · TafamidisClinical trials—Industry payments6Publications—Camzyosgeneric · MavacamtenClinical trials—Industry payments4Publications—Entrestogeneric · Sacubitril / valsartanClinical trials—Industry payments3Publications—NirmatrelvirClinical trials—Industry payments3Publications—Leqviogeneric · InclisiranClinical trials—Industry payments2Publications—Arcalystgeneric · RilonaceptClinical trials—Industry payments1Publications—Comirnatygeneric · SARS-CoV-2 (COVID-19) vaccine, mRNA spike proteinClinical trials—Industry payments1Publications—Keveyisgeneric · DichlorphenamideClinical trials—Industry payments1Publications—Livalogeneric · PitavastatinClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Abbott LaboratoriesClinical trials—Industry payments503Boston Scientific CorporationClinical trials—Industry payments194Biosense Webster, Inc.Clinical trials—Industry payments29Sanofi-Aventis U.S. LLCClinical trials—Industry payments19Medtronic, Inc.Clinical trials—Industry payments15Pfizer Inc.Clinical trials—Industry payments14iRhythm Technologies, Inc.Clinical trials—Industry payments12Philips Electronics North America CorporationClinical trials—Industry payments8AltaThera Pharmaceuticals LLCClinical trials—Industry payments6Biotronik Inc.Clinical trials—Industry payments6E.R. Squibb & Sons, L.L.C.Clinical trials—Industry payments6Atricure, Inc.Clinical trials—Industry payments5Novartis Pharmaceuticals CorporationClinical trials—Industry payments5Medical Device Business Services, Inc.Clinical trials—Industry payments4AstraZeneca Pharmaceuticals LPClinical trials—Industry payments2Impulse Dynamics (USA) Inc.Clinical trials—Industry payments2Kestra Medical Technology Services, Inc.Clinical trials—Industry payments2Amgen Inc.Clinical trials—Industry payments1Bardy Diagnostics, Inc.Clinical trials—Industry payments1Cardiva Medical, Inc.Clinical trials—Industry payments1Ebr Systems, Inc.Clinical trials—Industry payments1Electrophysiology Research FoundationClinical trials1Industry payments—Janssen Pharmaceuticals, IncClinical trials—Industry payments1Kansas City Heart Rhythm Research FoundationClinical trials1Industry payments—Kiniksa Pharmaceuticals International, plcClinical trials—Industry payments1Kowa Pharmaceuticals America, Inc.Clinical trials—Industry payments1University of LouisvilleClinical trials1Industry payments—Xeris Pharmaceuticals, Inc.Clinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
433publications

Distinct works indexed by OpenAlex, matched via ORCID; 52 in PubMed.

9,626citations

Total citations across indexed works.

41h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
3clinical trials

Investigator role on registered studies.

View trials ↓
27companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 14 Oct 2026

Listed as an investigator on 3 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 14 Oct 2026

27 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    54.4%
    Beta blocker21.2%
    Metoprolol Succinate66%Carvedilol17%Sotalol17%
    Part D<11 patients
    Antiarrhythmic20.5%
    Amiodarone Hcl48%Flecainide Acetate25%Dofetilide20%Propafenone Hcl7%
    Part D<11 patients

    + 5 more classes in this area

  • Blood & clotting

    30.9%
    Factor Xa inhibitor18.9%
    Eliquis82%Xarelto18%
    Part D≥51 patients
    P2Y12 inhibitor12.1%
    Clopidogrel100%
    Part D≥50 patients
  • Metabolism & gastrointestinal

    14.7%
    Proton pump inhibitor7.4%
    Pantoprazole Sodium100%
    Part D≥56 patients
    Aluminum Complex7.4%
    Sucralfate100%
    Part D≥58 patients
Where care is delivered (Part B)18.7% facility · 81.3% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Updated 14 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Online presence

Updated 14 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/rakesh-gopinathannair-md

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
  • LinkedIn

    linkedin.com/in/rakesh-gopinathannair-7308214

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗

Mentions by others

where others cite or feature them
  • Other

    esc365.escardio.org/person/983156

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →esc365.escardio.org ↗
  • Other

    hrsonline.org/person/rakesh-gopinathannair

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hrsonline.org ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 14 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hrsonline.org ↗
  • verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hrsonline.org ↗
  • verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →acc.org ↗
  • Board Certified

    Clinical Cardiac Electrophysiology

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hrsonline.org ↗

Editorial & leadership roles

journal and society appointments
  • verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hrsonline.org ↗
  • Immediate Past Chair

    Heart Rhythm Society Communications Committee

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hrsonline.org ↗
  • Past Chair

    American Heart Association Electrocardiography and Arrhythmias Committee

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hrsonline.org ↗
  • Associate Editor

    Heart Rhythm Case Reports

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hrsonline.org ↗
  • Peer reviewer for JACC

    European Heart Journal, Heart Rhythm, and other cardiovascular journals

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hrsonline.org ↗
  • Electrophysiology Medical Director

    Research Medical Center (Kansas City, MO)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healthykcmag.com ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.